Detection of antibodies against SARS-CoV-2 in patients with COVID-19.
作者信息
Du Zhe, Zhu Fengxue, Guo Fuzheng, Yang Bo, Wang Tianbing
机构信息
Trauma Center, Peking University People's Hospital, Beijing, China.
Tongji Medical College, Tongji Hospital, Institute of Organ Transplantation, Huazhong University of Science and Technology, Wuhan, China.
出版信息
J Med Virol. 2020 Oct;92(10):1735-1738. doi: 10.1002/jmv.25820. Epub 2020 Apr 10.
Abstract
摘要
相似文献
1
Detection of antibodies against SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎患者中抗新型冠状病毒 2 抗体的检测
J Med Virol. 2020 Oct;92(10):1735-1738. doi: 10.1002/jmv.25820. Epub 2020 Apr 10.
2
Serosurvey of SARS-CoV-2 among hospital visitors in China.中国医院访客中新型冠状病毒2型血清学调查。
Cell Res. 2020 Sep;30(9):817-818. doi: 10.1038/s41422-020-0371-0. Epub 2020 Jul 20.
3
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎（COVID-19）患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
4
Antibody responses against SARS-CoV-2 in COVID-19 patients.COVID-19患者针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的抗体反应。
J Med Virol. 2021 Jan;93(1):144-148. doi: 10.1002/jmv.26241. Epub 2020 Aug 2.
5
Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.新冠病毒疾病（COVID-19）癌症患者中抗SARS-CoV-2 IgG抗体的低流行率。
Int J Cancer. 2020 Dec 1;147(11):3267-3269. doi: 10.1002/ijc.33148. Epub 2020 Jun 27.
6
Seroconversion and kinetic of anti SARS-COV-2 antibodies in 25 patients with hematological malignancies who recovered from SARS-COV-2 infection.25例从新型冠状病毒肺炎感染中康复的血液系统恶性肿瘤患者的血清转化及抗新型冠状病毒2抗体动力学
Hematol Oncol. 2021 Aug;39(3):428-431. doi: 10.1002/hon.2872. Epub 2021 May 5.
7
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.等离子体基表面上血清和唾液中 SARS-CoV-2 抗体的抗体亲和力定量和准确检测。
Nat Biomed Eng. 2020 Dec;4(12):1188-1196. doi: 10.1038/s41551-020-00642-4. Epub 2020 Oct 29.
8
Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2.血清的热失活会干扰对 SARS-CoV-2 抗体的免疫分析。
J Clin Lab Anal. 2020 Sep;34(9):e23411. doi: 10.1002/jcla.23411. Epub 2020 Jun 28.
9
Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge.康复期新冠患者出院后100天内SARS-CoV-2特异性IgG、IgM和IgA水平下降
Sci China Life Sci. 2021 Mar;64(3):482-485. doi: 10.1007/s11427-020-1805-0. Epub 2020 Aug 28.
10
Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.日本 COVID-19 大流行期间癌症患者与医护人员间 SARS-CoV-2 抗体状态的差异。
JAMA Oncol. 2021 Aug 1;7(8):1141-1148. doi: 10.1001/jamaoncol.2021.2159.
引用本文的文献
1
Nine-Month Trend of IgG Antibody Persistence and Associated Symptoms Post-SARS-CoV-2 Infection.新型冠状病毒感染后IgG抗体持久性及相关症状的九个月趋势
Healthcare (Basel). 2024 May 5;12(9):948. doi: 10.3390/healthcare12090948.
2
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies.用高滴度中和抗体简单预测 COVID-19 恢复期血浆单位。
Virol J. 2023 Mar 27;20(1):53. doi: 10.1186/s12985-023-02007-0.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
SARS-CoV-2-on-Chip for Long COVID Management.用于长新冠管理的 SARS-CoV-2-on-Chip
Biosensors (Basel). 2022 Oct 18;12(10):890. doi: 10.3390/bios12100890.
5
Validation of the COVID-19 IgG/IgM Rapid Test Cassette (BNCP - 402 and BNCP402) in a South African setting.新型冠状病毒肺炎IgG/IgM快速检测试剂盒（BNCP - 402和BNCP402）在南非环境中的验证。
S Afr J Infect Dis. 2022 Aug 31;37(1):431. doi: 10.4102/sajid.v37i1.431. eCollection 2022.
6
Molecular and Serologic Diagnostic Technologies for SARS-CoV-2.新型冠状病毒2019（SARS-CoV-2）的分子和血清学诊断技术
ArXiv. 2022 Apr 26:arXiv:2204.12598v2.
7
The Effect of Convalescent Plasma in Patients With Covid-19 in Intensive Care Unit.新冠肺炎患者重症监护病房中使用恢复期血浆的效果。
In Vivo. 2022 May-Jun;36(3):1342-1348. doi: 10.21873/invivo.12836.
8
Disposable biosensors based on metal nanoparticles.基于金属纳米颗粒的一次性生物传感器。
Sens Int. 2022;3:100169. doi: 10.1016/j.sintl.2022.100169. Epub 2022 Mar 2.
9
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals.SARS-CoV-2 疫苗接种在未感染和先前感染过 COVID-19 的个体中引发非常规的 IgM 特异性反应。
EBioMedicine. 2022 Mar;77:103888. doi: 10.1016/j.ebiom.2022.103888. Epub 2022 Feb 20.
10
Micro/nano biomedical devices for point-of-care diagnosis of infectious respiratory diseases.用于传染性呼吸道疾病即时诊断的微纳生物医学装置。
Med Nov Technol Devices. 2022 Jun;14:100116. doi: 10.1016/j.medntd.2022.100116. Epub 2022 Feb 12.
本文引用的文献
1
Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department.VivaDiag新冠病毒IgM/IgG快速检测在用于急诊科急性患者的新冠病毒诊断时表现不佳。
J Med Virol. 2020 Oct;92(10):1724-1727. doi: 10.1002/jmv.25800. Epub 2020 Apr 8.
2
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).分析早期体液免疫反应以诊断新型冠状病毒病（COVID-19）。
Clin Infect Dis. 2020 Jul 28;71(15):778-785. doi: 10.1093/cid/ciaa310.
3
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.新型冠状病毒感染诊断用快速 IgM-IgG 联合抗体检测试剂的研制与临床应用
J Med Virol. 2020 Sep;92(9):1518-1524. doi: 10.1002/jmv.25727. Epub 2020 Apr 13.
4
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.感染患者上呼吸道标本中的新型冠状病毒2型病毒载量
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.
Zotero 插件